2954-50-9 | 1,2,3,4-Tetrahydronaphthalen-2-amine

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$56.00	$39.00
250mg	95%	in stock	$89.00	$62.00
1g	95%	in stock	$193.00	$135.00
5g	95%	in stock	$619.00	$433.00
10g	95%	in stock	$914.00	$640.00
25g	95%	in stock	$1,816.00	$1,271.00

Description

• Catalog Number: AB38093
• Chemical Name: 1,2,3,4-Tetrahydronaphthalen-2-amine
• CAS Number: 2954-50-9
• Molecular Formula: C10H13N
• Molecular Weight: 147.21692000000004
• MDL Number: MFCD00045577
• SMILES: NC1CCc2c(C1)cccc2

Computed Properties

• Complexity: 133
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Undefined Atom Stereocenter Count: 1
• XLogP3: 2.1

Literature

• Regioisomerism in the synthesis of a chiral aminotetralin drug compound: unraveling mechanistic details and diastereomer-specific in-depth NMR investigations.

  The Journal of organic chemistry 20120706

• Transdermal iontophoretic delivery of a novel series of dopamine agonists in vitro: physicochemical considerations.

  The Journal of pharmacy and pharmacology 20100601

• Functional primary amines and diamines from alpha-aminoacids. a concise route to substituted 2-aminotetralins.

  Organic letters 20090820

• [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.

  The Journal of pharmacology and experimental therapeutics 20090701

• Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.

  Journal of medicinal chemistry 20090528

• Synthesis and antifungal activities of novel 2-aminotetralin derivatives.

  Journal of medicinal chemistry 20071101

• 2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601

• Cyanobacterial lipopolysaccharides and human health - a review.

  Environmental health : a global access science source 20060101

• Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.

  Journal of medicinal chemistry 20040729

• In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.

  Shock (Augusta, Ga.) 20040101

• A synthetic overview of new molecules with 5-HT1A binding affinities.

  Mini reviews in medicinal chemistry 20030301

• A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors.

  Bioorganic & medicinal chemistry letters 20020225

• Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity.

  Journal of medicinal chemistry 19961011

• Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.

  Journal of medicinal chemistry 19941125